Congenital antithrombin III deficient neonate treated with antithrombin III concentrates
- PMID: 8327986
- DOI: 10.1016/0049-3848(93)90127-a
Congenital antithrombin III deficient neonate treated with antithrombin III concentrates
Abstract
A patient with antithrombin III deficiency developed deep vein thrombosis during her first pregnancy. Her pregnancy and delivery were successfully treated with simultaneous administration of antithrombin III concentrates and low molecular weight heparin. She delivered a 2,412g girl at 39 weeks' gestation. The baby was administered with antithrombin III concentrates as prophylaxis for neonatal arterial and venous thrombosis because the antithrombin III level was extremely low to be 2%. Her second pregnancy was uneventful at 38 weeks' gestation, and she was treated with administration of antithrombin III concentrates prophylactically. She delivered a 3,256g boy at 42 weeks' gestation without any complications. The antithrombin III level of the second baby was normal. These results showed that in a neonate with congenital antithrombin III deficiency the antithrombin III concentrates would be administered to prevent neonatal arterial and venous thrombosis.
Similar articles
-
Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement treatment.Acta Paediatr. 1996 Feb;85(2):245-7. doi: 10.1111/j.1651-2227.1996.tb14003.x. Acta Paediatr. 1996. PMID: 8640060
-
Acquired antithrombin III deficiency: replacement with antithrombin III concentrates in a patient with protein S deficiency accelerates response to therapy.Acta Haematol. 1993;90(3):151-4. doi: 10.1159/000204398. Acta Haematol. 1993. PMID: 8291376
-
Treatment of venous thrombosis in antithrombin III deficient patients with concentrates of antithrombin III.Clin Lab Haematol. 1982;4(2):101-8. Clin Lab Haematol. 1982. PMID: 7116792
-
Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.Am J Med. 1989 Sep 11;87(3B):53S-60S. doi: 10.1016/0002-9343(89)80533-9. Am J Med. 1989. PMID: 2679072 Review.
-
[Congenital deficiency of antithrombin III].Haematologica. 1990 Mar-Apr;75 Suppl 2:6-13. Haematologica. 1990. PMID: 2201606 Review. Italian. No abstract available.
Cited by
-
Perinatal stroke: a case-based review.Eur J Pediatr. 2012 Feb;171(2):225-34. doi: 10.1007/s00431-011-1509-3. Epub 2011 Jun 25. Eur J Pediatr. 2012. PMID: 21706130 Review.
-
Pharmacokinetics of protein C and antithrombin in the fetal lamb: a model to predict human neonatal replacement dosing.Neonatology. 2009;95(4):279-85. doi: 10.1159/000178025. Epub 2008 Nov 27. Neonatology. 2009. PMID: 19039246 Free PMC article.
-
Low molecular weight heparins: a guide to their optimum use in pregnancy.Drugs. 2002;62(3):463-77. doi: 10.2165/00003495-200262030-00004. Drugs. 2002. PMID: 11827560 Review.
-
Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature.Case Rep Hematol. 2017;2017:9261351. doi: 10.1155/2017/9261351. Epub 2017 Jan 10. Case Rep Hematol. 2017. PMID: 28168066 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources